The Supreme Court is scheduled to hear petitions on April 16 challenging the validity of the Waqf (Amendment) Act, 2025, following Presiden...

Jawed had joined the role in June 2018 after quitting Novartis within 15 days of being appointed to lead the Swiss drug company’s India bus...

The brokerage said Abbott India’s net profit for the third quarter was 30% ahead of estimate due to record EBITDA margin.

Abbott will also look at partnering with e-pharmacies, diagnostic chains and physicians to provide patients with discounts.

Buy Abbott India Ltd. at a price target of Rs 8480.0 and a stoploss at Rs 7840 from entry point.

Paleja, previously president and head of pharmaceuticals for Novartis Indonesia, will also head Novartis India's pharmaceutical business, a...

Abbott in the second largest drug maker in India but it competes with Novartis in several therapy areas like cardiovascular, and diabetes. ...

Novartis India, with domestic sales of nearly Rs 1,200 crore, has been battling it out in the Indian market with several drug companies in ...

The board, the filing said, has requested the nomination and remuneration committee to identify and recommend a suitable successor for the ...

In recent years, the country has been home to about 69 million diabetics.

The court said it can't make a definitive conclusion that Novartis' imports of Onbrez were insufficient to meet the demands COPD patients f...

According to the judgment, Cipla had claimed that 10 tablets of Onbrez cost Rs 677 as opposed to its own drug priced at Rs 130.

Akhilesh had also insisted on sacking Raghuraj Pratap Singh "Raja Bhaiyya" in 2013, after his name cropped up in the murder of Deputy SP Zi...

SP Jain Institute of Management and Research (SPJIMR) has launched a capacity building programme for community caregivers and NGOs working ...

Novartis Healthcare has launched secukinumab, used for the treatment of plaque psoriasis in adult patients, in India. The company has launc...

In fact, pharma MNCs in India are growing faster than their local counterparts: according to AIOCD data, they expanded 13.8 per cent in Jul...

These companies not only had to battle slow growth but also the fickle stand of Indian government over issues of intellectual property and ...